XML 66 R38.htm IDEA: XBRL DOCUMENT v3.2.0.727
Equity Instruments - Significant Assumptions (Detail)
9 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Jun. 30, 2014
Jun. 30, 2013
Luoxis Diagnostics [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected volatility       86.00%
Expected volatility, minimum 79.00%   79.00%  
Expected volatility, maximum 108.00%   82.00%  
Risk free interest rate, minimum 0.75%   0.75% 1.04%
Dividend yield 0.00%   0.00% 0.00%
Risk free interest rate, maximum 2.09%   1.53% 1.53%
Vyrix Pharmaceuticals [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected volatility, minimum 63.00% 63.00%    
Expected volatility, maximum 76.00% 76.00%    
Risk free interest rate, minimum 0.90% 0.90%    
Dividend yield 0.00% 0.00%    
Risk free interest rate, maximum 2.02% 2.02%    
Warrant [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected volatility 87.00%      
Risk free interest rate 0.52%      
Expected term (years) 5 years      
Dividend yield 0.00%      
Minimum [Member] | Luoxis Diagnostics [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected term (years) 5 years   5 years 5 years
Minimum [Member] | Vyrix Pharmaceuticals [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected term (years) 5 years 5 years    
Maximum [Member] | Luoxis Diagnostics [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected term (years) 7 years   6 years 6 months 6 years 6 months
Maximum [Member] | Vyrix Pharmaceuticals [Member]        
Assumptions Used To Determine Fair Value Options [Line Items]        
Expected term (years) 6 years 6 months 6 years 6 months